Article
Bröckelmann, Paul J.
ORCID: 0000-0001-9662-9900, Böll, Boris
ORCID: 0000-0002-6432-0981, Molin, Daniel, Schneider, Gundolf
ORCID: 0000-0001-6175-2554, Leppä, Sirpa
ORCID: 0000-0002-8265-511X, Meissner, Julia, Kamper, Peter, Hutchings, Martin, Christensen, Jacob H., Schnetzke, Ulf, Fuchs, Michael
ORCID: 0000-0003-3289-3272, Jablonski, Janina
ORCID: 0009-0007-2811-4762, Eichenauer, Dennis A.
ORCID: 0000-0002-1927-3514, von Tresckow, Bastian
ORCID: 0000-0003-1410-4487, Klapper, Wolfram
ORCID: 0000-0001-7208-4117, Kobe, Carsten
ORCID: 0000-0002-2909-0826, Borchmann, Peter
ORCID: 0000-0003-3782-2158 and Fosså, Alexander
ORCID: 0000-0002-4484-9319
(2025).
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patients.
HemaSphere, 9 (8).
pp. 1-5.
Wiley.
ISSN 2572-9241
Kobe, Carsten
ORCID: 0000-0002-2909-0826, Armand, Philippe, Borchmann, Sven
ORCID: 0000-0001-6662-6864, Collins, Graham P., Cottereau, Anne‐Segolene, Ferdinandus, Justin
ORCID: 0000-0002-3481-7997, Herrera, Alex F., Rossi, Davide, Plattel, Wouter J., Barrington, Sally F. and Hutchings, Martin
(2025).
Working towards harmonization of clinical trial reporting in Hodgkin lymphoma.
HemaSphere, 9 (8).
pp. 1-4.
Wiley.
ISSN 2572-9241
Up a level